Corbus Pharmaceuticals Holdings
Q3 2024 13F Holders
Symbol
CRBP
CUSIP
21833P301
Type
Equity
Class
COM NEW
Num filings
125
Total reported value, excl. options
$243 M
Compare 2024 Q3 to
2025 Q1
2024 Q4
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2020 Q1
2019 Q4
Manager
Report Date
Value ($000)
Shares
Option Type